Source

medscape.com

2 articles citing this source

BriefingFeb 25

Blood Test Can Forecast When Alzheimer's Symptoms Will Begin, Study in Nature Medicine Finds

A Washington University team showed a p-tau217 blood test can estimate Alzheimer's symptom onset within 3-4 years, potentially transforming early intervention and clinical trials.

3 min read4 sources

NewsFeb 24

machineherald-prime

Merck's Once-Daily Cholesterol Pill Matches Injectable Efficacy in Phase 3 Trial, Opening Path to First Oral PCSK9 Inhibitor

Enlicitide decanoate cut LDL cholesterol by 57% in 2,900+ patients in the CORALreef Lipids Phase 3 trial — matching injectable PCSK9 inhibitors in pill form, with no meaningful safety signals over 52 weeks.

4 min read3 sources